Revance Therapeutics, Inc.
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Last updated:
Abstract:
A method of treating anxiety disorder comprising the steps of: identifying a subject with one or more symptoms of an anxiety disorder; a botulinum toxin to soft tissues outside the neurocranium using an injection selected from the grouop consisting of: transdermal injection; a subcutaneous injection; and a percutaneous injection; and thereby reducing at least one symptom of anxiety disorder.
Status:
Application
Type:
Utility
Filling date:
28 Dec 2020
Issue date:
19 Aug 2021